HomeCompareCNRAF vs MRK

CNRAF vs MRK: Dividend Comparison 2026

CNRAF yields 5.57% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $32.4K in total portfolio value
10 years
CNRAF
CNRAF
● Live price
5.57%
Share price
$1.49
Annual div
$0.08
5Y div CAGR
-12.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.4K
Annual income
$180.13
Full CNRAF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CNRAF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCNRAFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CNRAF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CNRAF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CNRAF
Annual income on $10K today (after 15% tax)
$473.59/yr
After 10yr DRIP, annual income (after tax)
$153.11/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,175.30/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CNRAF + MRK for your $10,000?

CNRAF: 50%MRK: 50%
100% MRK50/50100% CNRAF
Portfolio after 10yr
$40.6K
Annual income
$4,989.13/yr
Blended yield
12.30%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CNRAF
No analyst data
Altman Z
1.9
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CNRAF buys
0
MRK buys
0
No recent congressional trades found for CNRAF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCNRAFMRK
Forward yield5.57%2.76%
Annual dividend / share$0.08$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-12.5%32.7%
Portfolio after 10y$24.4K$56.8K
Annual income after 10y$180.13$9,798.13
Total dividends collected$3.2K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CNRAF vs MRK ($10,000, DRIP)

YearCNRAF PortfolioCNRAF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,188$487.51$11,206$366.19$18.00MRK
2$12,417$446.01$12,650$502.35$233.00MRK
3$13,691$404.80$14,407$694.19$716.00MRK
4$15,014$364.99$16,585$967.82$1.6KMRK
5$16,392$327.33$19,342$1,363.89$3.0KMRK
6$17,832$292.25$22,913$1,947.19$5.1KMRK
7$19,340$259.98$27,662$2,823.89$8.3KMRK
8$20,925$230.58$34,159$4,173.35$13.2KMRK
9$22,593$204.00$43,337$6,308.80$20.7KMRK
10$24,355$180.13$56,776$9,798.13$32.4KMRK

CNRAF vs MRK: Complete Analysis 2026

CNRAFStock

Vicinity Centres (Vicinity or the Group) is one of Australia's leading retail property groups. With a fully integrated asset management platform, and $24 billion in retail assets under management across 63 shopping centres, it is the second largest listed manager of Australian retail property. Vicinity has a Direct Portfolio with interests in 60 shopping centres (including the DFO Brisbane business) and manages 31 assets on behalf of Strategic Partners, 28 of which are co-owned by the Group. Vicinity is listed on the Australian Securities Exchange (ASX) under the code 'VCX' and has over 28,000 securityholders. Vicinity also has European medium term notes listed on the ASX under the code 'VCD'.

Full CNRAF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CNRAF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CNRAF vs SCHDCNRAF vs JEPICNRAF vs OCNRAF vs KOCNRAF vs MAINCNRAF vs JNJCNRAF vs ABBVCNRAF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.